HST — Host Hotels & Resorts, Inc.

The setup is genuinely two-sided as of 2026-09-13. Bulls point to the Q2 2026 print (revenue $1.64B, +3.4% YoY, EPS $0.34, Adjusted FFO $0.63 beating by a penny), the raised FY2026 RevPAR/Total RevPAR guidance of 4.75%–5.25%, a World Cup demand boost, a Buy consensus (23 Buy vs. 18 Hold, 2 Sell) and a ~$25.47 average price target. Bears point to price action: HST fell roughly 6% in the weeks after the August 5 report and is down 10.65% over three months even as estimates went up, which reads as the market discounting the durability of luxury/group demand and REFIT-multiple pressure from rates rather than the near-term numbers. With RSI at 41.62 and price 4.67% below its 50-day, the tape says 'cooling,' not 'broken' — hence Neutral rather than Bullish or Bearish.

Revenue growth is positive but clearly decelerating on a reported YoY basis: quarterly revenue went $1,471M (Q1'24) → $1,466M (Q2'24) → $1,594M (Q1'25) → $1,586M (Q2'25) → $1,331M (Q3'25) → $1,603M (Q4'25) → $1,645M (Q1'26) → $1,640M (Q2'26). That's YoY growth of +8.4% in Q1'25, +8.2% in Q2'25, +0.9% in Q3'25, +12.3% in Q4'25, then +3.2% in Q1'26 and +3.4% in Q2'26 — a step down from the ~8% pace of early 2025 to ~3% in H1 2026, with the Q4'25 spike largely a soft-comparison artifact. Operating margin in the seasonally strong quarters is quietly expanding: 17.9% in Q1'26 vs. 17.9% in Q1'25 (flat) and 17.9% in Q2'26 vs. 17.5% in Q2'25, while the seasonally weak Q3 compresses hard (7.6% in Q3'25 vs. 10.2% in Q3'24). The cleaner signal is cash: TTM free cash flow of ~$1,013M (Q2'26 $382M + Q1'26 $220M + Q4'25 $349M + Q3'25 $62M) versus ~$807M in the prior TTM window, up ~26%. Important caveat: reported net income is badly distorted by one-offs — Q1 2026 net income of $494M dwarfed operating income of $312M, and Q3 2025 net income of $161M exceeded operating income of $101M, both from asset-sale/condo gains. This is a modest but real recovery story where growth is currently decelerating while management guides for re-acceleration in H2 2026; it is not a structural decline.

Fair, leaning modestly cheap against its own history. As of 2026-09-13 the trailing P/E of 15.13x sits below the 4-year average of 17.64x, and P/S of 2.449 is below the 5-year average of 2.68. But two distortions matter: (1) TTM EPS of $1.483 includes outsized one-off gains from the Four Seasons condo asset sales, so the trailing multiple flatters the 'clean' earnings power — applying the Street's next-FY EPS estimate of $1.378 to the $22.24 price gives a forward P/E of ~16.1x, i.e. HIGHER than trailing, not lower; (2) the PEG of 0.268 is not usable given the one-off distortions. The 7.04% dividend yield is also misleading — stripping the $0.72 special, the recurring quarterly dividend is closer to $0.20/share, or roughly a 3.6% forward yield. On EV/EBITDA (~9.0x per the ratio screener, or ~10x on the $18.4B EV against the $1.82–$1.84B FY2026 EBITDAre guidance), HST is not expensive for investment-grade, gateway-market lodging exposure.

The price is not keeping up with the estimate revisions — and that's the story. Management raised FY2026 guidance in August 2026, yet the stock fell ~6% post-print and is down 10.65% over three months. The market is effectively saying it does not believe the 4.75%–5.25% RevPAR growth guidance is durable into a 2027 that loses the World Cup tailwind, and it is applying a rate-driven discount to the whole REIT sector. Two things to watch rather than GAAP EPS: Adjusted FFO and EBITDAre, because GAAP EPS will look meaningfully worse in FY2027 as the condo/asset-sale gains roll off (next-FY EPS estimate of $1.378 is below TTM $1.483 even though core operations should improve). If H2 2026 delivers on guidance and the Manchester Grand Hyatt San Diego renovation drag converts into a 2027 tailwind, the ~16x forward multiple is re-rating material; if RevPAR growth stalls at ~3%, the stock is roughly fairly valued here and goes nowhere.

As of 2026-09-13, the technical setup is a short-term downtrend inside a longer-term uptrend: RSI(14) at 41.62 (neutral, tilting weak — not oversold), price 1.05% below the 20-day SMA, 4.67% below the 50-day SMA, but still 5.77% ABOVE the 200-day SMA. One-week return is +0.86% and six-month is +20.15%, versus -2.46% over one month and -10.65% over three months — so the momentum damage is recent, not chronic. Practical read: the stock is range-bound between roughly $22 and the $25.71 high, and it is sitting on the wrong side of its 20- and 50-day averages, which means entry timing is mediocre right now. A patient buyer would want either an RSI flush toward the low-to-mid 30s or a decisive reclaim of the 50-day before treating this as a clean entry; the 200-day at roughly $21 is the line that, if lost, would signal the longer-term uptrend is genuinely broken.

• Fed policy path and long-bond yields: HST is capital-intensive with a 1.10 beta and $5.08B of long-term debt, so REIT multiples and refinancing costs move directly with the rate curve.
• Luxury/upper-upscale leisure and group demand durability: affluent travel has held up, but any normalization in high-end consumer spending hits HST's rate-driven revenue model faster than midscale peers.
• Gateway urban market concentration: heavy exposure to New York, Miami, San Francisco and Los Angeles ties RevPAR to international inbound travel and local convention calendars, which are lumpy.
• Operating cost inflation: labor and property insurance continue to pressure hotel-level margins, muting the flow-through of RevPAR gains to EBITDAre.
• Event-driven demand pull-forward: 2026 World Cup and other events flatter current RevPAR but set up harder 2027 comparisons across the same gateway markets.

• Q3 2026 earnings release (expected late October/early November 2026) — the key test of whether the raised 4.75%–5.25% RevPAR guidance is reaffirmed, tightened or cut, plus any update on labor and insurance cost trends.
• Manchester Grand Hyatt San Diego renovation milestones — room inventory returns progressively through early 2027, so renovation drag converts into top-line acceleration and ROI.
• Further asset sales and special-dividend potential — HST has already monetized the Four Seasons condo project; additional dispositions would add capital-return optionality.
• Fed rate cuts or a decline in the 10-year Treasury, which would re-rate REIT multiples broadly and lower HST's cost of capital.
• Continued group and international inbound booking strength in gateway markets, supported by event calendars into 2027.

• Decelerating reported growth is real: YoY revenue growth fell from ~8% in early 2025 to ~3.2%–3.4% in H1 2026, and a further slowdown in RevPAR would undercut the raised guidance that the bull case leans on.
• Rate sensitivity: as a leveraged REIT, higher-for-longer rates pressure both the multiple and refinancing costs despite the investment-grade balance sheet.
• Earnings-quality/optics risk: TTM EPS of $1.483 is inflated by one-off condo and asset-sale gains, and next-FY EPS estimates of $1.378 are lower — headline P/E could look WORSE in 2027 even if core operations improve, which can spook momentum investors.
• Dividend yield is overstated at 7.04% — the Q2 2026 payout of $0.92 included a $0.72 special dividend; the recurring yield is closer to 3.6%, a disappointment risk for income-focused buyers.
• Renovation execution and storm remediation costs — capex is guided at $550M–$630M for FY2026, and overruns or delays at the Manchester Grand Hyatt would extend the drag on results.

HST is a decent business trading at a fair price, not a bargain and not a trap. The balance sheet is genuinely strong (82.7 financial-health score, 2.77 current ratio, investment-grade debt), free cash flow is growing ~26% YoY, and the stock trades below its own 4-year average P/E with analysts at a Buy and ~$25.47 average target. But the reported growth deceleration to ~3% and the 10.65% three-month drawdown say the market isn't paying for the raised guidance yet, and TTM earnings are flattered by one-offs. Expect a roughly range-bound stock with a modest upward tilt if H2 2026 delivers on RevPAR — the risk/reward is roughly balanced here, so this is a position to accumulate on weakness, not chase. This is analysis, not personalized financial advice.

Blended EV/EBITDA and AFFO approach as of 2026-09-13: applying a 10.75x multiple (a modest premium to HST's current ~9.0x screener EV/EBITDA, roughly in line with luxury lodging REIT peers and below its own mid-cycle range) to the FY2026 EBITDAre guidance midpoint of $1.83B gives an EV of ~$19.67B; subtracting net debt of ~$3.13B ($5.08B long-term debt less $1.95B cash) leaves ~$16.54B of equity, or ~$24.15/share on ~685M shares. Cross-checked against ~12.5x normalized FY2026 AFFO/share of roughly $1.95–$2.00 (~$25.00), which blends to approximately $24.50 — about 10% above the $22.24 price, consistent with but slightly below the $25.47 analyst consensus.